Search for: "Sun Pharmaceutical Industries Limited"
Results 1 - 20 of 33
Sorted by Relevance | Sort by Date
RSS Subscribe:  20 results  |  100 results
14 Jan, 2007 9:47 pm by Aaron Barkoff
... approved for the relief of certain side effects of chemotherapy and radiation therapy. Sun Pharmaceutical Industries filed an ANDA to market a generic version of Ethyol. In what appears to have become ... No. 5,424,471 and denied Sun's motion for summary judgment of nonfringement as to the other patent in suit, U.S. Patent No. 5,591, ... , 927 F.2d 1565 (Fed. Cir. 1991), that the claimed product is not limited by the process steps. The court, however, thought the better rule was set forth in Atlantic ...
Orange Book Blog - http://www.orangebookblog.com/
18 Nov, 2008 10:40 pm by Varun
... development, Orion Corporation has filed a patent lawsuit (in the US District Court for the District of New Jersey) against Sun Pharmaceutical Industries Limited for alleged infringement of OB listed US Patent No. 5,446,194 (the '194 patent) for Stalevo, a combination drug (carbidopa, levodopa and entacapone) for the treatment of Parkinson disease. The lawsuit is result of Sun's submission of an ANDA seeking marketing approval for generic Stalevo tablets before the expiration of the '194 ...
Patent Circle - http://patentcircle.blogspot.com/
30 Jul, 2007 7:10 pm by Donald Zuhn
By Sherri Oslick -- About Court Report: Each week we will report briefly on recently filed biotech and pharma cases, and a few interesting cases will be selected for periodic monitoring. Sanofi-Aventis U S LLC et al. v. Sun Pharmaceutical Industries, Limited et al.2:07-cv-13107; filed July 24, 2007 in the...
Patent Docs - http://patentdocs.typepad.com/patent_docs/
20 Jun, 2008 8:07 am
... Uroxatral (Alfuzosin) - US: Sanofi asserts second Uroxatral patent against Sun Pharmaceuticals Industries: (IP Law360), Xyzal (Levocetrizine) - US: Sepracor and UCB sue ... Can!!!) India Supreme Court judgment in trade mark case Khoday Distilleries Limited v The Scotch Whisky Association: (International Law Office) Iran Iran's ... Juustutoeoestus OUE: (Class 46) New Zealand New Zealand to be 'consulted' on ACTA (Industry Standard): (IP Justice), IP provisions in NewZealand-China Free Trade Agreement: ...
IP Thinktank - http://duncanbucknell.com/blog
8 Dec, 2007 11:00 am
... s fees despite earlier win against Teva: (IPLaw360), Exelon (Rivastigmine) - Sun Pharmaceutical Industries and Watson Pharmaceuticals settle with Novartis: (IPLaw360), (Generic Pharmaceuticals & IP), (BIO Smartbrief), Levaquin (Levofloxacin) - Supreme Court ... Union has taken steps to ratify a 2005 decision by the WTO designed to ensure that intellectual property does not limit access to medicines in developing countries: (IPWatch), (Lenz Blog), (IPR-Helpdesk), London agreement operation by mid ...
IP Thinktank - http://duncanbucknell.com/blog
30 May, 2008 9:09 am
... ), Xyzal (Levocetrizine) - US: UCB SA and Sepracor file lawsuit against Sun Pharmaceuticals to stave off launch of generic Xyzal: (IP Law360) Zyprexa (Olanzapine) ... law overview: (IPKat), Microsoft and refusal to license - Report on 'The Microsoft case: the IT industry and the future of EC competition law' conference: (IPKat) ECJ: works covered by ... so): 'accused products and methods did not meet any of the thirteen limitations of the ten asserted claims': Rattler Tools v Bilco Tools: (Hal Wegner), ...
IP Thinktank - http://duncanbucknell.com/blog
29 Feb, 2008 8:00 am
... FTC's suit against Cephalon testing the legality of entering into 'pay for delay' settlements: (California Biotech Law Blog), Rispen (Risperidone) - Sun Pharmaceuticals files post-grant opposition in respect of Janssen Pharmaceutical's Indian patent for ... ca Inc: (Canadian Trademark Blog), CIPO releases updated tools to assist practitioners in drafting and filing industrial design applications, including sample drawings: (ipblog.ca), ITWorldCanada covers emergence of Business Coalition for Balanced ...
IP Thinktank - http://duncanbucknell.com/blog
16 Nov 1:16 am
... the amount of insurance available. One of the perennial questions in D&O insurance placement is the issue of "limits adequacy" - that is, the question of how much insurance is enough. The significant extent to which these settlements exceeded the available insurance ... 's remarks, as well as Cassin's own comments on the prospects for increased FCPA enforcement activity in the pharmaceutical industry. And in This Week's Ponzi Scheme News: I was struck by the news late last week that prosecutors ...
The D & O Diary - http://www.dandodiary.com/
16 Aug, 2008 2:43 am
... (Patent Docs), (update - Patent Docs), Rising drug prices - the real devil in detail: (IPmed), Brazil probes pharmaceutical industry for building high-cost drug demand: (Intellectual Property Watch), Brazil: Generic drugs surge in Brazil as ... standard prosecution): (The Invent Blog), Third party submission of information during patent prosecution: (Ezine @rticles), PTO limits scope of patent agent representation: Changes to representation of others before the USPTO (final rule): (Peter Zura's 271 ...
IP Thinktank - http://duncanbucknell.com/blog
8 Feb, 2008 7:00 pm
... (Daptomycin) - Corrected Cubist patent now relisted in Orange Book: (GenericsWeb) Depakote (Valproate semisodium) - Abbot sues Sun Pharmaceuticals to block generic Depakote: (IP Law360), Enbrel (etanercept ) / Kineret (Anakinra) - Federal judge allows Amgen ... Name Dispute Resolution Policy: (Australian Trade Marks Law Blog), Trade Marks Office finds 'Dirty Kustoms Industries' deceptively similar to 'Kustoms': (Mondaq), Federal Court finds infringement of copyright in project home plans in Gaunt v ...
IP Thinktank - http://duncanbucknell.com/blog
6 Jun, 2008 6:49 am
... Alexandria: (Patent Docs), 15-16 October: ACI 9th annual maximising pharmaceutical patent life cycles - New York: (Patent Baristas) Pharma & Biotech ... survives re-examination: (Patent Docs), Xyzal (Levocetirizine) - US: Sepracor sues Sun Pharmaceuticals for patent infringement over ANDA for generic Xyzal: (Patent Docs) Africa ... IPKat) Delhi High Court prohibits Yahoo Video from streaming Super Cassettes Industries' music: (Ars Technica), (Techdirt), Creativity and fashion under Indian copyright ...
IP Thinktank - http://duncanbucknell.com/blog
20 Oct, 2007 7:34 am by Jean Jin
... Spanish on a comprehensive database, encompassing almost 4000 years of knowledge. [6] Although a lobbyist from the pharmaceutical industry scoffed at the project as "a solution in search of a problem," the project director revealed that the "need for the database ... knowledge and subject matter freely given should be encumbered by a grant of royalties based on information in the (limited) public domain. The Rio Treaty has placed the burden on countries to determine how they will exercise their ...
The Journal of the Business Law Society - http://www.law.uiuc.edu/bljournal/
18 Oct, 2007 11:00 pm
... IPR::JUR), (IAM), Teva invalidates acid metabolite patents for terfenedine, (Teva Pharmaceutical Industries Ltd and another v Merrell Pharmaceuticals Inc, Aventis and Sepracor [2007] EWHC 2276 (Ch) ), ... jasmine with a unique lingering fragrance) gets Geographican Indication status (SpicyIP), PhillipinesPhillipines enacts a provision limiting pharmaceutical extension patents which is similar to India's renouned s 3(d) (Spicy IP) USA Amazon's one-click patent rejected by USPTO (Against Monopoly), ( ...
IP Thinktank - http://duncanbucknell.com/blog
21 Jan, 2007 8:53 pm by Aaron Barkoff
... generated sales of approximately $350 million last year for Ortho-McNeil. Caraco is majority-owned by Sun Pharmaceutical, the fifth largest generic drug maker in India, while Ortho-McNeil is a wholly ... ), No. 02-CV-5707-JCL-MF (D. N.J.), and Teva Pharmaceutical Industries, Ltd., No. 04-CV-886-HAA-GDH (D. N.J). (The ... an average weight ratio of 1:8.67 would render meaningless the "about 1:5" limitation. In reviewing the district court's claim construction de novo, the Federal Circuit found no error in ...
Orange Book Blog - http://www.orangebookblog.com/
28 Feb, 2008 1:52 am by rparloff
... , modify, and redistribute without fear that their work will ever be taken out of circulation, declared off-limits, or placed behind a toll-booth by private proprietors. (For a feature story on the tension between patents and free and ... to seek patent reforms, and it hopes to find of way of placating the tech industry without weakening protections for the drug patents that are the lifeblood of the pharmaceutical industry.) Though many information technology companies, like IBM, Hewlett-Packard, ...
FORTUNE: Legal Pad - http://money.cnn.com/blogs/legalpad/
4 Apr, 2008 1:00 am
... web 2.0 world - 43(B)log), (Copyright law exceptions and limitations - 43(B)log), (Free speech and P2P issues - 43(B)log ... consider public interest in allowing or rejecting an order of injunction: (Indian Patent Oppositions), (Generic Pharmaceuticals & IP), (Spicy IP), (International Law Office), (Spicy IP), Topamax ( ... coupon copying limits by deleting certain computer files: (Techdirt), CSIRO - eSeis files suit against Australia's Commonwealth Scientific and Industrial Research Organisation, ...
IP Thinktank - http://duncanbucknell.com/blog
15 Feb, 2008 9:00 am
... & IP); (more from Generic Pharmaceuticals & IP), Is the Indian drug industry scared of the National Pharmaceutical Pricing Authority?: (Spicy IP), USD 20 billion going ... questioning validity on ground of enhanced efficacy: (Patent Circle), (Spicy IP), (Generic Pharmaceuticals & IP) Africa South African Gap trade mark litigation: (Afro- ... activities: (IPR-Helpdesk), Coexistence of GIs: (Class 46), (IP Updates), ECJ limit on free movement of DVDs: Dynamic Medien v Avides Media: (IPKat), EU ...
IP Thinktank - http://duncanbucknell.com/blog
11 Jul, 2008 4:30 am
... @ Gowlings), Canada: PMPRB annual report for 2007: (Pharmacapsules @ Gowlings), Canada: Mergers increasing in the life sciences industry: (Pharmacapsules @ Gowlings), India: Drug patent linkage controversy: a middle path solution?: (Spicy IP), India: Ranbaxy ... (Amlodipine/Olmesartan) / Benicar (Olmesartan) - US: Daiichi Sankyo's patent infringement suit against Mylan Pharmaceuticals over Azor consolidated with another dispute between the companies over related drug Benicar: (IP Law360), Carbatrol ...
IP Thinktank - http://duncanbucknell.com/blog
13 Jun, 2008 3:40 am
... Docs), 23 September: CLT 3rd annual IP law and the fashion industry conference - London: (IPKat), 24 September: 2008 INTA/WIPO international forum ... dismisses Sanofi-Aventis' patent claims against generic Oxaliplatin maker Boryung Pharmaceutical Co: (GenericsWeb), Eloxatin (Oxaliplatin) - US: Sanofi-Aventis files patent infringement ... IP), Compulsory licensing and the copyright holder: Entertainment Network Limited v Super Cassettes Industries: (Spicy IP), Toshiba v Toshiba: Procedural history and ...
IP Thinktank - http://duncanbucknell.com/blog
7 Mar, 2008 2:00 am
... ) - Watson applies to market generic Seasonique, prior to the expiration of patents owned by Duramed, a subsidiary of Barr Pharmaceuticals - Barr sues Watson: (GenericsWeb), (IP Law360), (Philip Brooks), Tarceva (Erlotinib) - Indian Patent Office ... Syria Syrian Arab Republic accedes to Hague Agreement Concerning International Registration of Industrial Designs (Geneva Act): (IPKat) Turkey Landmark decision on time limits in trade mark cancellation actions: (International Law Office) United Kingdom ...
IP Thinktank - http://duncanbucknell.com/blog
        Next >
Add to your RSS Reader Add to your Google Add to your My Yahoo Add to your My MSN Add to your My AOL Add to your Feedster Add to your Newsgator Add to your Bloglines Add to your NewsBurst Add to your Rojo Add to your Pluck